cas 124433-70-1|| where to buy 6-Fluoropyridine-2-sulfonamide

Nom du produit:6-Fluoropyridine-2-sulfonamide

IUPAC Name:6-fluoropyridine-2-sulfonamide

Unité d'emballage	Stock disponible	Prix($)
CM294876-250mg	in stock	ƀƦ
CM294876-1g	in stock	ƦưŴ
CM294876-5g	1-2 Weeks	ƀȁƦ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 124433-70-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:124433-70-1; Formule moléculaire:C5H5FN2O2S; Point de fusion:-; Code SMILES:O=S(C1=NC(F)=CC=C1)(N)=O; Densité:

: Numéro de catalogue:CM294876; Poids moléculaire:176.17; Point d'ébullition:; N° Mdl:MFCD18816593; Stockage:Keep in inert atmosphere, store at 2-8°C.

: Pyridines; Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.; Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu; Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer; Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

: Vanzacaftor; Vertex Pharmaceuticals announced that Health Canada has accepted for review its New Drug Submission (NDS) for vanzacaftor/tezacaftor/deutivacaftor, a once-daily triple combination therapy for people living with cystic fibrosis (CF) ages 6 years and older who have at least one F508del mutation or another responsive mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Vanzacaftor is a small molecule cystic fibrosis transmembrane conductance regulator (CFTR). Vanzacaftor is also undergoing regulatory review in multiple other jurisdictions, including by the Food and Drug Administration (FDA) in the U.S. and by the European Medicines Agency (EMA) in the E.U.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.